Invivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe

Biomaterials

Volumn 34, Issue 36, 2013, Pages 9149-9159

  Ryu, Ju Hee ^a,b   Shin, Miyoung ^a,c   Kim, Sun Ah ^a   Lee, Sangmin ^a   Kim, Hyunjoon ^a   Koo, Heebeom ^a   Kim, Byung Soo ^b   Song, Hyun Kyu ^c   Kim, Sun Hwa ^a   Choi, Kuiwon ^a   Kwon, Ick Chan ^a,c   Jeon, Hyesung ^a   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Seoul National University   (South Korea)

^c Korea University   (South Korea)

Author keywords

Cancer imaging; EGF based nanoprobe; Epidermal growth factor (EGF); Epidermal growth factor receptor (EGFR); Receptor targeted imaging

Indexed keywords

CANCER IMAGING; EPIDERMAL GROWTH FACTOR RECEPTORS; EPIDERMAL GROWTH FACTORS; FLUORESCENCE IMAGING; FLUORESCENCE SIGNALS; INTRAVENOUS INJECTIONS; LOW-MOLECULAR WEIGHT; LYSOSOMAL DEGRADATION;

DISEASES; FLUORESCENCE; INFRARED DEVICES; MEDICAL IMAGING; MOLECULAR WEIGHT; MONOCLONAL ANTIBODIES; NANOPROBES; TUMORS;

DIAGNOSIS;

CELL MARKER; CELL PROTEIN; CETUXIMAB; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR BASED NANOPROBE; EPIDERMAL GROWTH FACTOR RECEPTOR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYPEPTIDE; UNCLASSIFIED DRUG; NANOPARTICLE; DIAGNOSTIC AGENT;

ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BINDING ASSAY; CANCER DIAGNOSIS; CONTROLLED STUDY; DEGRADATION; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG TARGETING; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYSOSOME; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NANOFABRICATION; NANOPROBE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PERMEABILITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; FLUORESCENCE; INTRACELLULAR SPACE; METABOLISM; NEOPLASMS; PROCEDURES; TUMOR CELL LINE; CANCER IMAGING; EGF-BASED NANOPROBE; EPIDERMAL GROWTH FACTOR (EGF); EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); METHODOLOGY; NEOPLASM; RECEPTOR-TARGETED IMAGING;

ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; EPIDERMAL GROWTH FACTOR; FLUORESCENCE; HUMANS; INTRACELLULAR SPACE; MICE; NANOPARTICLES; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECTROSCOPY, NEAR-INFRARED;

CANCER IMAGING; EGF-BASED NANOPROBE; EPIDERMAL GROWTH FACTOR (EGF); EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); RECEPTOR-TARGETED IMAGING;

EID: 84883753482     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.026     Document Type: Article

References (35)

1. Bai M., Bornhop D.J. Recent advances in receptor-targeted fluorescent probes for invivo cancer imaging. Curr Med Chem 2012, 19:4742-4758.
2. Lin J.J., Chen J.S., Huang S.J., Ko J.H., Wang Y.M., Chen T.L., et al. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials 2009, 30:5114-5124.
3. Becker A., Hessenius C., Licha K., Ebert B., Sukowski U., Semmler W., et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001, 19:327-331.
4. Li K., Ding D., Huo D., Pu K.-Y., Thao N.N.P., Hu Y., et al. Conjugated polymer based nanoparticles as dual-modal probes for targeted invivo fluorescence and magnetic resonance imaging. Adv Funct Mater 2012, 22:3107-3115.
5. Bhattacharyya S., Khan J.A., Curran G.L., Robertson J.D., Bhattacharya R., Mukherjee P. Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater 2011, 23:5034-5038.
6. Gao J., Liu W., Xia Y., Li W., Sun J., Chen H., et al. The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes. Biomaterials 2011, 32:3459-3470.
7. Gao J., Yu Y., Zhang Y., Song J., Chen H., Li W., et al. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials 2012, 33:270-282.
8. Lee J.S., Groothuis T., Cusan C., Mink D., Feijen J. Lysosomally cleavable peptide-containing polymersomes modified with anti-EGFR antibody for systemic cancer chemotherapy. Biomaterials 2011, 32:9144-9153.
9. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
10. Ang K.K., Berkey B.A., Tu X., Zhang H.-Z., Katz R., Hammond E.H., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002, 62:7350-7356.
11. Marega R., De Leo F., Pineux F., Sgrignani J., Magistrato A., Naik A.D., et al. Functionalized Fe-filled multiwalled carbon nanotubes as multifunctional scaffolds for magnetization of cancer cells. Adv Funct Mater 2013, 23:3173-3184.
12. 3/C nanoshells for MR imaging and NIR therapeutic applications. Adv Funct Mater 2009, 19:249-258.
13. Heskamp S., Laverman P., Rosik D., Boschetti F., van der Graaf W.T., Oyen W.J., et al. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. JNucl Med 2012, 53:146-153.
14. Gong H., Kovar J., Little G., Chen H., Olive D.M. Invivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 2010, 12:139-149.
15. Van de Broek B., Devoogdt N., D'Hollander A., Gijs H.L., Jans K., Lagae L., et al. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 2011, 5:4319-4328.
16. Bhirde A.A., Patel V., Gavard J., Zhang G., Sousa A.A., Masedunskas A., et al. Targeted killing of cancer cells invivo and invitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009, 3:307-316.
17. Thomas T.P., Shukla R., Kotlyar A., Liang B., Ye J.Y., Norris T.B., et al. Dendrimer-epidermal growth factor conjugate displays superagonist activity. Biomacromolecules 2008, 9:603-609.
18. Creixell M., Bohórquez A.C., Torres-Lugo M., Rinaldi C. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano 2011, 5:7124-7129.
19. Diagaradjane P., Orenstein-Cardona J.M., Colón-Casasnovas N.E., Deorukhkar A., Shentu S., Kuno N., et al. Imaging epidermal growth factor receptor expression invivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 2008, 14:731-741.
20. Ke S., Wen X., Gurfinkel M., Charnsangavej C., Wallace S., Sevick-Muraca E.M., et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 2003, 63:7870-7875.
21. Lee S., Ryu J.H., Park K., Lee A., Lee S.-Y., Youn I.-C., et al. Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination invivo. Nano Lett 2009, 9:4412-4416.
22. Ryu J.H., Lee A., Chu J.-U., Koo H., Ko C.-Y., Kim H.S., et al. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe. Arthritis Rheum 2011, 63:3824-3832.
23. Ryu J.H., Kim S.A., Koo H., Yhee J.Y., Lee A., Na J.H., et al. Cathepsin B-sensitive nanoprobe for invivo tumor diagnosis. JMater Chem 2011, 21:17631-17634.
24. Lee S., Choi K.Y., Chung H., Ryu J.H., Lee A., Koo H., et al. Real time, high resolution video imaging of apoptosis in single cells with a polymeric nanoprobe. Bioconjug Chem 2011, 22:125-131.
25. Yoon H.Y., Koo H., Choi K.Y., Lee S.J., Kim K., Kwon I.C., et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33:3980-3989.
26. Lacroix M., Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83:249-289.
27. Na J.H., Koo H., Lee S., Min K.H., Park K., Yoo H., et al. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials 2011, 32:5252-5261.
28. Hama Y., Urano Y., Koyama Y., Kamiya M., Bernardo M., Paik R.S., et al. Atarget cell-specific activatable fluorescence probe for invivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res 2007, 67:2791-2799.
29. Oishi M., Tamura A., Nakamura T., Nagasaki Y. Asmart nanoprobe based onfluorescence-quenching PEGylated nanogels containing gold nanoparticles for monitoring the response to cancer therapy. Adv Funct Mater 2009, 19:827-834.
30. Roepstorff K., Grandal M.V., Henriksen L., Knudsen S.L., Lerdrup M., Grøvdal L., et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 2009, 10:1115-1127.
31. Gorden P., Carpentier J.L., Cohen S., Orci L. Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A 1978, 75:5025-5029.
32. Ogawa M., Regino C.A.S., Seidel J., Green M.V., Xi W., Williams M., et al. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem 2009, 20:2177-2184.
33. Sailor M.J., Park J.-H. Hybrid nanoparticles for detection and treatment of cancer. Adv Mater 2012, 24:3779-3802.
34. Reilly R.M., Kiarash R., Sandhu J., Lee Y.W., Cameron R.G., Hendler A., et al. Acomparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. JNucl Med 2000, 41:903-911.
35. Jia L., Zhang L., Shao C., Song E., Sun W., Li M., et al. An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes. PLoS One 2009, 4:e5146.